A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab

<div>Clinical course showing decreased levels of AFP after the serial courses of chemotherapy with carboplatin and paclitaxel plus bevacizumab. After the recurrence, levels of AFP rapidly increased regardless of latter treatment with pemetrexed (PEM), docetaxel (DTX), and S-1 plus bevacizumab.</div>

Case Reports in Oncological Medicine

fig3

Figure 3

Figure 3: A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab 